title: Etanercept decreases HMGB1 expression in dorsal root ganglion neuron cells in a rat chronic constriction injury model.
abstract: In the present study, we examined the effect of etanercept on high mobility group box 1 (HMGB1) expression in dorsal root ganglion (DRG) neuron cells in a rat model of chronic constriction injury (CCI) of the sciatic nerve, with the aim of exploring the molecular mechanism underlying the therapeutic effect of etanercept on sciatica-related nociception and the potential interaction between tumor necrosis factor-α (TNF-α) and HMGB1 in DRG neuron cells. A rat CCI model was employed and the animals were randomly assigned to seven groups (n=20/group): untreated, sham only, sham/saline, sham/etanercept, CCI only, CCI/saline and CCI/etanercept. Our results revealed that compared with the sham/saline and sham/etanercept groups, thermal hyperalgesia and mechanical hyperalgesia, as well as HMGB1 expression at both the mRNA and protein levels in the DRG neuron cells, were induced by CCI, and were significantly inhibited by etanercept. Although etanercept showed no significant effect on the sham group, it significantly reduced the phosphorylated p38 mitogen-activated protein kinase (MAPK) levels induced by CCI in the DRG neuron cells. In conclusion, we demonstrated that etanercept significantly decreased the HMGB1 expression induced by CCI in the DRG neuron cells. This study not only explored the molecular mechanisms underlying the therapeutic effect of etanercept on sciatica-related nociception, but also provided indirect evidence for an interaction between TNF-α and HMGB1 in DRG neuron cells.
authors: Department of Anesthesiology, Xiangya Hospital, Central South University, Changsha, Hunan 410008,  P.R. China.
authors: Rui-Ke
authors: RK
authors: Wang
authors: Qin-Qin
authors: QQ
authors: Zhang
authors: Yun-Dan
authors: YD
authors: Pan
authors: Qu-Lian
authors: QL
authors: Guo
keywords: chronic constriction injury; dorsal root ganglion; etanercept; high mobility group box 1; mitogen-activated protein kinase; tumor necrosis factor-α
references: Annu Rev Immunol. 2011;29:139-62
references: 21219181
references: J Neurophysiol. 1997 Jan;77(1):484-90
references: 9120589
references: Expert Opin Biol Ther. 2012 Jun;12 Suppl 1:S217-24
references: 22620489
references: Mol Pharmacol. 2006 Feb;69(2):520-31
references: 16291872
references: Pain. 1988 Apr;33(1):87-107
references: 2837713
references: Microbiol Mol Biol Rev. 2004 Jun;68(2):320-44
references: 15187187
references: Cytokine. 2009 Jul;47(1):23-9
references: 19398208
references: J Peripher Nerv Syst. 2001 Jun;6(2):67-72
references: 11446385
references: Pain. 2010 Jun;149(3):514-521
references: 20392563
references: Autoimmun Rev. 2010 Aug;9(10):661-5
references: 20546955
references: Autoimmun Rev. 2012 Oct;11(12):909-17
references: 22495229
references: Biochem Biophys Res Commun. 2009 Jul 24;385(2):132-6
references: 19379716
references: Exp Neurol. 2007 Mar;204(1):355-65
references: 17258708
references: Cardiovasc Pathol. 2008 May-Jun;17(3):129-38
references: 18402807
references: Spine (Phila Pa 1976). 2011 May 15;36(11):E692-8
references: 21217446
references: J Immunol. 2003 Apr 1;170(7):3890-7
references: 12646658
references: Spine (Phila Pa 1976). 2008 Feb 1;33(3):227-34
references: 18303453
references: Neurosci Lett. 2003 Aug 28;347(3):179-82
references: 12875915